#78: FastFun: Gilead Announces New LetairisTM (ambrisentan) Data and Amgen Claims Win in Patent Lawsuit
Biotechnology industry alert provided by U.S. Equity News. Gilead... |
October 24, 2007
02:28:31 PM |
#77: FastFun: Illumina Launches MicroRNA Assay for Gene Expression Profiling
New, Low-Cost Research Application Will Play Critical Role in... |
October 24, 2007
02:27:59 PM |
#76: FastFun: Illumina to Announce Third Quarter 2007 Earnings Results on Tuesday, October 23, 2007
Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results... |
October 24, 2007
02:26:17 PM |
#75: FastFun: Illumina Announces Multi-Million Dollar Agreement with the University of Virginia and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
6,500 Sample Contract Marks the Largest Whole-Genome Association... |
October 24, 2007
02:24:24 PM |
#74: NewsBot: ILMN News Illumina Announces Outcome of First Phase of Its Patent Litigation against Affymetrix
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) announced today that a... |
March 13, 2007
12:31:00 PM |
#73: NewsBot: ILMN News Illumina to Present at the Cowen and Company, Citigroup, and Lehman Brothers Conferences
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) announced today that Jay... |
March 8, 2007
03:54:00 PM |
#72: NewsBot: ILMN News Former CSO of Illumina, Dr. David Barker, Joins NextBio Board of Directors
CUPERTINO, Calif.--(BUSINESS WIRE)--NextBio today announced that Dr. David L.... |
March 6, 2007
05:00:00 AM |
#71: NewsBot: ILMN News Illumina Named Senior Party in Interference Proceeding Challenging Ownership Rights for Patent Covering Affymetrix Technology
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced the United... |
March 1, 2007
02:15:00 PM |
#70: NewsBot: ILMN News Illumina Announces $75 Million Share Repurchase Program
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced that it has... |
February 27, 2007
03:00:00 AM |
#69: NewsBot: ILMN News Illumina Closes $400 Million Convertible Senior Notes
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ: ILMN) today announced the closing of... |
February 16, 2007
10:32:00 AM |
#67: NewsBot: ILMN News deCODE Receives Illumina CSPro(TM) Certification for Delivering Top Quality SNP Genotyping Services
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) announced today that deCODE... |
February 14, 2007
03:00:00 AM |
#68: NewsBot: ILMN News Asuragen Becomes the First Certified Service Provider for Illumina Gene Expression Profiling
AUSTIN, Texas & SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) and... |
February 14, 2007
03:00:00 AM |
#66: NewsBot: ILMN News Illumina Prices $350 Million Convertible Senior Notes
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced the pricing of... |
February 13, 2007
03:05:00 AM |
#65: NewsBot: ILMN News Researchers Announce ''Breakthrough Discovery'' in Type-2 Diabetes Using Illumina's HumanHap300 and Human-1 Genotyping BeadChips
SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced that... |
February 13, 2007
03:00:00 AM |
#64: NewsBot: ILMN News Illumina Unveils Industry's Most Comprehensive Whole-Genome DNA Analysis Solution
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN)
today announced... |
January 10, 2007
08:55:00 AM |
| 
| 
| 
| 
| 
| 
